Embecta Corp. Share Price

Embecta Corp. Share Price

NASDAQ: EMBC | Small Cap
$6.57
+$0.13 (1.94%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Embecta Corp. Stock Performance

Open
$6.51
Prev. Close
$6.45
Circuit Range
N/A
Day Range
$6.45 - $6.68
Year Range
$2.77 - $14.88
Volume
35,431
Average Traded
$6.60

Embecta Corp. Share Price Today

As of 30 October 2026, Embecta Corp.'s share price is $6.57. The stock opened at $6.51, compared to its previous close of $6.45. During today's trading session, Embecta Corp.'s share price traded between $6.45 and $6.68, with an average price of $6.57. Over the past 52 weeks, the stock has recorded a high of $14.88 and a low of $2.77. In terms of performance, Embecta Corp.'s share price has declined by 28.28% over the last six months and is down 50.68% on a year-on-year basis.

Embecta Corp. Share Price Chart

Line chart of the Embecta Corp. price trend over the selected period. The price rose overall, ranging from 6.45 to 6.70, ending at 6.57.
$6.45$6.68
L
Show Current Price
H

Embecta Corp. Stock Fundamentals & Key Indicators

Market Cap
$382.18M
PE Ratio (TTM)
4.18
Dividend Yield
7.43%
EPS (TTM)
$1.54
Revenue (TTM)
$1.08T
Return On Equity (TTM)
-14.28%
Profit Margin
8.83%
Debt to Equity
-2.43
Quarterly Earnings Growth YoY
-20.08%

Embecta Corp. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$264.00$261.20$221.80$271.70
Net Profit$26.40$44.10-$4.10$21.10
Net Profit Margin10.00%16.88%-1.85%7.77%
Income ChangeN/A67.05%-109.30%614.63%

Embecta Corp. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1129.50$1120.80$1123.10$1080.40
Net Profit$223.60$70.40$78.30$95.40
Net Profit Margin19.80%6.28%6.97%8.83%
Income ChangeN/A-68.52%11.22%21.84%

About Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Embecta Corp. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$5.74
$6.56
+15.80%
Sep 2026
$5.09
$5.67
+14.10%
Aug 2026
$3.74
$4.96
+36.21%
Jul 2026
$3.33
$3.65
+11.64%
Jun 2026
$3.35
$3.27
-3.12%
May 2026
$9.17
$3.37
-63.21%
Apr 2026
$8.79
$9.16
+3.62%
Mar 2026
$10.02
$8.84
-13.80%
Feb 2026
$10.65
$10.26
-3.53%
Jan 2026
$11.89
$10.63
-10.60%
Dec 2025
$12.71
$11.89
-6.82%
Nov 2025
$13.32
$12.76
-4.20%

EMBC Share Price FAQs